Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy (Q46121548)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 February 2009

Language	Label	Description	Also known as
English	Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy	scientific article published on 13 February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P Hadji

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

M Ziller

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

D G Kieback

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

W Dornoff

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

H W Tessen

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

T Menschik

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

J Kuck

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

F Melchert

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

A Hasenburg

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

publication date

13 February 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

Annals of Oncology

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

20

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

1203-1209

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Bone loss and fracture risk associated with cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

The causes and treatment of bone loss associated with carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Practical guidance for the management of aromatase inhibitor-associated bone loss

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN762

21 January 2018

Identifiers

10.1093/ANNONC/MDN762

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19218306

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46121548&oldid=2093435542"